IL6 and COVID-19: A modest increase in the circulating levels of pro-inflammatory cytokines further corroborated previous studies [88,89] and highlighted another crucial difference in patients suffering from complicated COVID-19 that present almost threefold higher levels of the pro-inflammatory cytokine IL-6 compared to patients with an uncomplicated form of the disease [90].